Marion McCourt, EVP Commercial at REGENERON PHARMACEUTICALS, INC. (REGN), sold 2,276 shares at $980.16 ($2.2M) on 2024-06-03, disclosed to the SEC on 2024-06-05.
Scheduled sale ($2.2M) by EVP Commercial under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $980.16 | 1,138 | $1.1M | 50.0% |
| 2 | $980.16 | 1,138 | $1.1M | 50.0% |
| Total | $980.16 avg | 2,276 | $2.2M | 100% |
| Filing → |
| REGN | SELL | 2024-10-03 | $1.1M | — | Filing → |
| REGN | SELL | 2024-09-05 | $1.2M | — | Filing → |
| REGN | SELL | 2024-08-05 | $2.4M | — | Filing → |